Tumor‐Selective Activation of Toll‐Like Receptor 7/8 Agonist Nano‐Immunomodulator Generates Safe Anti‐Tumor Immune Responses upon Systemic Administration.
Saved in:
| Title: | Tumor‐Selective Activation of Toll‐Like Receptor 7/8 Agonist Nano‐Immunomodulator Generates Safe Anti‐Tumor Immune Responses upon Systemic Administration. |
|---|---|
| Authors: | Hao, Yanyun1 (AUTHOR), Li, Hui1 (AUTHOR), Ge, Xiaoyan1 (AUTHOR), Liu, Yang1 (AUTHOR), Li, Xia1 (AUTHOR), Liu, Yutong1 (AUTHOR), Chen, Hongfei1 (AUTHOR), Zhang, Shiying1 (AUTHOR), Zou, Jing1 (AUTHOR), Huang, Lingling1 (AUTHOR), Zhao, Fabao2 (AUTHOR), Kang, Dongwei2 (AUTHOR), De Geest, Bruno G.3 (AUTHOR), Zhang, Zhiyue1 (AUTHOR) zhiyue.zhang@sdu.edu.cn |
| Source: | Angewandte Chemie. 12/23/2022, Vol. 134 Issue 52, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00448249 |
|---|---|
| DOI: | 10.1002/ange.202214992 |
